ArticlePharmaceutics2022

Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart.

Javad Garousi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.